Alliancebernstein L.P. Inovio Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $36,182 - $87,478	45,800 Added 13.21%	392,400 $321,000
Q4 2022 Feb 14, 2023	BUY	$1.41 - $2.5 $93,342 - $165,500	66,200 Added 23.61%	346,600 $540,000
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $591,327 - $1.04 Million	-199,100 Reduced 41.52%	280,400 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $998,000 - $1.49 Million	200,000 Added 71.56%	479,500 $2.39 Million
Q3 2021 Nov 10, 2021	SELL	$7.16 - $9.69 $250,600 - $339,150	-35,000 Reduced 11.13%	279,500 $2 Million
Q2 2021 Jul 30, 2021	BUY	$6.23 - $10.03 $595,588 - $958,867	95,600 Added 43.67%	314,500 $2.92 Million
Q1 2021 May 06, 2021	BUY	$8.81 - $16.96 $37,002 - $71,232	4,200 Added 1.96%	218,900 $2.03 Million
Q3 2020 Nov 12, 2020	SELL	$9.57 - $27.05 $431,894 - $1.22 Million	-45,130 Reduced 17.37%	214,700 $2.49 Million
Q2 2020 Aug 13, 2020	BUY	$7.14 - $31.69 $976,966 - $4.34 Million	136,830 Added 111.24%	259,830 $7 Million
Q1 2020 May 14, 2020	SELL	$2.98 - $14.09 $125,160 - $591,780	-42,000 Reduced 25.45%	123,000 $915,000
Q2 2019 Aug 14, 2019	BUY	$2.29 - $4.1 $103,737 - $185,729	45,300 Added 37.84%	165,000 $485,000
Q1 2019 May 14, 2019	SELL	$3.34 - $5.1 $10,354 - $15,809	-3,100 Reduced 2.52%	119,700 $446,000
Q4 2018 Feb 13, 2019	BUY	$3.89 - $6.11 $35,399 - $55,601	9,100 Added 8.0%	122,800 $491,000
Q3 2018 Nov 08, 2018	SELL	$3.92 - $5.58 $27,048 - $38,502	-6,900 Reduced 5.72%	113,700 $632,000
Q2 2018 Aug 13, 2018	BUY	$3.88 - $5.16 $65,960 - $87,720	17,000 Added 16.41%	120,600 $473,000
Q1 2018 May 14, 2018	BUY	$4.05 - $5.69 $74,925 - $105,265	18,500 Added 21.74%	103,600 $488,000
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $456,136 - $542,087	85,100	85,100 $540,000

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $496M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account